Daniel Morganstern is an Oncology physician affiliated with Hartford Hospital. OpenAlex indexes 28 publications with 543 citations (h-index 12).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
201 N Mountain Rd Ste 202
Plainville, CT 060621848
Telephone
860-224-4408Provider last certified this registry record 21 Apr 2026.
Industry payments
19 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novartis Pharmaceuticals CorporationProgram year202512 payments
- Merck Sharp & Dohme LLCProgram year20251 payment
- Novartis Pharmaceuticals CorporationProgram year202412 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
86.7%Aromatase Inhibitor55.8%Letrozole62%Anastrozole32%Exemestane7%Part D≥105 patientsEstrogen Agonist/Antagonist27.9%Tamoxifen Citrate100%Part D≥86 patients+ 1 more class in this area
Nervous system
5.9%Gabapentinoids2.6%Gabapentin100%Part D<11 patientsOpioid Agonist1.7%Oxycodone Hcl100%Part D<11 patients+ 1 more class in this area
Genitourinary & hormones
3.3%Estrogen Agonist/Antagonist1.9%Raloxifene Hcl100%Part D<11 patientsEstrogen1.4%Estradiol100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Integrating polygenic risk scores into clinical breast cancer models: Influence on prediction in diverse cohorts.
Journal of Clinical Oncology
2023 - Phase II trial of carboplatin and bevacizumab in patients with breast cancer brain metastases
Breast Cancer Research
2020 - Trans‐counseling: A case series of transgender individuals at high risk for <i>BRCA1</i> pathogenic variants
Journal of Genetic Counseling
2019
Similar KOLs
Other experts from the same institution or the same specialty.
Mark Alberts, MD
Hartford Hospital
Karen Blank, MD
Hartford Hospital
Raymond McKay, MD
Hartford Hospital
Andrew Salner, MD
Hartford Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”